jain.com

Underwriters' over-allotment option exercise completed

Company: TeraWulf

Subject kind
financing
Statement date
2023-02-28
Promised amount
26.63 USD
Current status
stated

The claim, verbatim

The company received total net proceeds of approximately $26.63 million from a public offering, including the exercise of the underwriters' over-allotment option for an additional 1,000,000 shares at $0.68 per share.

Source (primary)

TeraWulf 8-K filed 2023-03-01 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 1,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $0.64 million, or approximately $26.63 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”

How we checked this

Attempted on September 21, 2026. We could not read enough of the cited source to check this claim.

The verification run did not return a result for this claim (claude -p exit 1: b'').

What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1083301/000108330123000024/wulf-20230301x8k.htm) in full (3,050 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms TeraWulf 8-K filed 2023-03-01

Quote: “the underwriters of the previously announced underwritten public offering of common stock of TeraWulf Inc. (the "Company"), exercised their option and purchased an additional 1,000,000 shares of the Company's common stock, par value $0.001 per share, from the Company at the public offering price of $0.68 per share, resulting in additional net proceeds to the Company of approximately $0.64 million, or approximately $26.63 million in total net proceeds after taking into account the exercise of the underwriters' option, in each case after deducting underwriting discounts and commissions and estimated offering expenses.”

View cached copy (2026-09-13)Live source ↗